萬裕科技(00894.HK)上半年盈轉虧至1775萬港元
格隆匯 8 月 29日丨萬裕科技(00894.HK)公佈,截至2020年6月30日止6個月,公司實現收入6.68億港元,同比增長17.9%;EBITDA4497.3萬港元,同比減少48.3%;股權持有人應占虧損1775萬港元,同期則盈利2707.1萬港元,每股虧損3.73港仙。
2019冠狀病毒病大流行之嚴重不利影響導致生產中斷和業務活動放緩,令集團於2020年第一季蒙受重大財務虧損。然而,2020年第二季銷售額強勁反彈,令整體收入較2019年同期上升17.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.